Dynavax TechnologiesDVAX
DVAX
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
68% more call options, than puts
Call options by funds: $8.17M | Put options by funds: $4.87M
31% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 29
25% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 5 (+1) [Q4]
20% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 80
16% more capital invested
Capital invested by funds: $1.44B [Q3] → $1.67B (+$224M) [Q4]
2% more funds holding
Funds holding: 250 [Q3] → 254 (+4) [Q4]
0.32% more ownership
Funds ownership: 98.97% [Q3] → 99.29% (+0.32%) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$10
15%
downside
Avg. target
$25
110%
upside
High target
$33
181%
upside
3 analyst ratings
2 positive
67%
0 neutral
0%
1 negative
33%
Goldman Sachs Paul Choi 67% 1-year accuracy 10 / 15 met price target | 15%downside $10 | Sell Maintained | 17 Apr 2025 |
Citizens Capital Markets Jason Butler 29% 1-year accuracy 12 / 41 met price target | 181%upside $33 | Market Outperform Maintained | 21 Feb 2025 |
HC Wainwright & Co. Edward White 22% 1-year accuracy 32 / 148 met price target | 164%upside $31 | Buy Reiterated | 21 Feb 2025 |
Financial journalist opinion
Based on 6 articles about DVAX published over the past 30 days
Neutral
PRNewsWire
1 day ago
Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
Mails Letter to Stockholders Urging Stockholders to Vote "FOR" All Four Dynavax Director Nominees on the GOLD Proxy Card EMERYVILLE, Calif. , April 29, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today mailed a letter to its stockholders in connection with its 2025 Annual Meeting of Stockholders ("Annual Meeting") urging stockholders to vote the GOLD proxy card "FOR" all four of Dynavax's highly qualified directors standing for election – Brent MacGregor, Scott Myers, Lauren Silvernail and Elaine Sun.
Neutral
PRNewsWire
1 week ago
Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
EMERYVILLE, Calif. , April 22, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report first quarter 2025 financial results on Tuesday, May 6, 2025, after the U.S. financial markets close.
Neutral
Business Wire
1 week ago
Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) (“Dynavax”, “DVAX” or the “Company”), with ownership of approximately 14.53% of the Company's outstanding shares, today announced that it has filed a definitive proxy statement in connection with its nomination of four highly qualified candidates for election to the Company's Board of Directors (the “B.
Neutral
PRNewsWire
1 week ago
Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders
Urges Stockholders to Vote "FOR" All Four Dynavax Director Nominees on the GOLD Proxy Card Highlights Record Financial and Operational Results, Balanced Capital Allocation Strategy andMeaningful Board Refreshment Underscores Deep Track's Value Destructive, Short-Term Focus and Unnecessary Proxy Contest EMERYVILLE, Calif. , April 17, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission ("SEC") in connection with its upcoming Annual Meeting of Stockholders scheduled to be held on June 11, 2025.
Neutral
Business Wire
2 weeks ago
Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”) is one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) (“Dynavax”, “DVAX” or the “Company”), with ownership of approximately 14.34% of the Company's outstanding shares. Today Deep Track commented on the Company's disclosure that the Board of Directors (the “Board”) has rejected a settlement proposal in connection with its nomination of four highly qualif.
Neutral
PRNewsWire
3 weeks ago
Dynavax Files Preliminary Proxy Statement
Dynavax's Board is Overseeing Record Operational and Financial Performance Outlines Extensive Engagement with Deep Track and Multiple Attempts to Reach a Resolution EMERYVILLE, Calif. , April 3, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today filed its preliminary proxy materials with the Securities and Exchange Commission ("SEC") in connection with its upcoming Annual Meeting of Stockholders ("the 2025 Annual Meeting").
Positive
Zacks Investment Research
1 month ago
Why Dynavax Technologies (DVAX) Stock Might be a Great Pick
Dynavax Technologies (DVAX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Positive
Zacks Investment Research
1 month ago
Wall Street Analysts See an 83.1% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High?
The consensus price target hints at an 83.1% upside potential for Dynavax Technologies (DVAX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Neutral
Business Wire
1 month ago
Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) (“Dynavax”, “DVAX” or the “Company”), with ownership of approximately 14.34% of the Company's outstanding shares, today sent a letter to the Company's Board of Directors (the “Board”) related to Deep Track's nomination of four highly qualified candidates for election to the Company's Board of Directors.
Neutral
PRNewsWire
1 month ago
Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
Opportunistic refinancing extends the maturity of most of existing debt with improved terms and reduces dilution to existing capital structure $225 million of convertible notes due in 2030 issued, including an exchange for the retirement of ~$185 million of existing convertible notes due in 2026 and ~$40 million of new money Dynavax repurchased ~$8 million of the Company's common stock in connection with this transaction EMERYVILLE, Calif. , March 6, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, has entered into privately negotiated exchange and subscription agreements (the "Exchange Agreements") with a limited number of holders of its outstanding 2.50% Convertible Senior Notes due 2026 (the "2026 Notes") and one new investor, pursuant to which the Company will issue $225 million aggregate principal amount of 2.0% Convertible Senior Notes due 2030 (the "New Notes") comprised of (i) an exchange for the retirement of approximately $185 million in aggregate principal amount of existing 2026 Notes, and (ii) approximately $40 million of New Notes issued to existing holders and one new investor (the "Transactions").
Charts implemented using Lightweight Charts™